International Whistleblower Rewards are being offered to International Whistleblowers that expose international bribery schemes, illegal kickbacks, and government corruption. Under the Foreign Corrupt Practices Act and the new SEC Whistleblower Incentive Program, whistleblowers with original and specialized knowledge and evidence of corporate bribery and illegal kickbacks are eligible to recover large economic awards.

The Globalization of International Trade and Standardization of Anti-bribery and Corruption Laws Have Led to the Enactment of International Whistleblower Laws That Reward International Professionals for Anonymously Exposing Foreign Corrupt Practices Act Violations Including Illegal Bribes, Supply Chain Fraud, and Accounting Fraud

Through globalization of international trade, there has been a shift in
many international manufacturing supply chains. As such, raw material
supplies for pharmaceuticals, medical supplies, medical equipment, electronics, and several other regulated products that have traditionally come from the United States and Europe are now
coming from China and India. This manufacturing shift has created an
environment where adulterated ingredients to pharmaceuticals, medical
supplies, and medical devices as well as counterfeit parts for weapons and electronics may be used in the manufacturing of products and can create dangerous and adulterated drugs, medical
supplies, and medical devices as well as dangerous and defective weapons, computers, aircraft, and vehicles.

For this reason international professionals are being offered large financial rewards to properly expose supply chain fraud including bribes, accounting fraud, and dangerous regulated products. Under SEC FCPA whistleblower reward laws, an international professional can report these Foreign Corrupt Practice Act violations anonymously through a lawyer to protect their identity and career from potential retaliation.

The Globalization of the Pharmaceutical Industry

Every year over $4.1 trillion (US dollars) is spent worldwide on health
services including approximately $850 billion (US dollars) that is spent
in the pharmaceutical market on drugs and medications. In 2011, it is
estimated that global pharmaceutical sales are expected to grow by 5% to
7% to around $880 billion. This growth in sales is led by the 17
so-called "pharmerging countries," which include China, Brazil, Russia,
India, Venezuela, Poland and the Ukraine. These "pharmerging
countries", are forecast to see their pharmaceutical spending grow at a
15% to 17% rate in 2011, to between $170 billion and $180 billion
overall.

Globalization of supply chains in international trade has created a
shift in where many component parts are produced. This shift includes
the production of electronic components that are used in aircraft,
military weapons systems, computers, medical equipment, and other
products that are purchased by the United States government through
procurement contracts. These electronic components were traditionally
manufactured in the United States and Europe, but are now being
manufactured in China, Mexico, India, and South America. When these
electronic components are fake or substandard parts, false
certifications regarding the quality of these electronic components can
be the subject of a Qui Tam False Claims Act Whistleblower Reward
Lawsuit. These lawsuits encourage whistleblowers including international
whistleblowers along the electronic component supply chain to blow the
whistle on fake military electronic components, low quality electronic
components, and other counterfeit electronic parts.